XML 19 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash Flows From Operating Activities:    
Net loss $ (40,147) $ (236,979)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Goodwill impairment charges   269,332
Depreciation and amortization 78,448 78,367
Amortization of debt issuance costs and discounts 2,311 2,467
Loss on early extinguishment of debt and write-off of discounts and debt issuance costs   8,143
Loss on sale or disposal of assets 7,651 1,948
Deferred benefit from income tax (11,823) (108,173)
Equity-based compensation 13,437 16,020
Changes in assets and liabilities:    
Accounts receivable (43,858) (23,037)
Inventories (8,882) (9,544)
Prepaid expenses and other current assets (558) 2,674
Accounts payable and accrued expenses 22,487 25,755
Accrued salaries, wages and benefits 7,783 (8,204)
Deferred revenue 87,724 72,278
Other accrued liabilities 13,050 (4,800)
Other assets and liabilities (809) 2,056
Net cash provided by operating activities 126,814 88,303
Cash Flows From Investing Activities:    
Capital expenditures (97,372) (103,175)
Other investing activities (477)  
Net cash used in investing activities (97,849) (103,175)
Cash Flows From Financing Activities:    
Proceeds from issuance of debt   998,306
Repayments of long-term debt (11,854) (1,015,056)
Proceeds from draw on revolving credit facility 55,000 80,649
Repayments of revolving credit facility (70,000) (65,000)
Debt issuance costs   (15,390)
Dividends paid to stockholders (304) (1,502)
Payment of tax withholdings on equity-based compensation through shares withheld (2,269) (1,470)
Exercise of stock options 1,185 11
Net cash used in financing activities (28,242) (19,452)
Change in Cash and Cash Equivalents, including Restricted Cash 723 (34,324)
Cash and Cash Equivalents, including Restricted Cash—Beginning of period 33,997 69,378
Cash and Cash Equivalents, including Restricted Cash—End of period 34,720 35,054
Supplemental Disclosures of Noncash Investing and Financing Activities    
Capital expenditures in accounts payable 32,715 33,132
Dividends declared, but unpaid $ 124 $ 665